Company profile
TENAX THERAPEUTICS, INC. insider acquisitions
Company CIK 0000034956 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| PurchaseCode P | Common StockNon-derivative · Currency not specified | 3 | 1,463,426.2084 | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
14 dated transactions · 5 of 5 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 21, 2026 | TENAX THERAPEUTICS, INC.Common Stock | Schneeberger Daniel · ADAR1 Capital Management, LLC | Purchase |
| Oct 20, 2026 | TENAX THERAPEUTICS, INC.Common Stock | Schneeberger Daniel · ADAR1 Capital Management, LLC | Purchase |
| Oct 19, 2026 | TENAX THERAPEUTICS, INC.Common Stock | Schneeberger Daniel · ADAR1 Capital Management, LLC | Purchase |
| Dec 9, 2025 | TENAX THERAPEUTICS, INC.Common Stock | Rich Stuart | Purchase |
| Dec 8, 2025 | TENAX THERAPEUTICS, INC.Common Stock | Rich Stuart | Purchase |
| Dec 4, 2025 | TENAX THERAPEUTICS, INC.Common Stock | Rich Stuart | Purchase |
| Dec 3, 2025 | TENAX THERAPEUTICS, INC.Common Stock | Rich Stuart | Purchase |
| Dec 2, 2025 | TENAX THERAPEUTICS, INC.Common Stock | Rich Stuart | Purchase |
| Nov 20, 2025 | TENAX THERAPEUTICS, INC.Common Stock | Giordano Christopher Thomas | Purchase |
| Nov 19, 2025 | TENAX THERAPEUTICS, INC.Common Stock | Giordano Christopher Thomas | Purchase |
| Nov 18, 2025 | TENAX THERAPEUTICS, INC.Common Stock | Giordano Christopher Thomas | Purchase |
| Nov 17, 2025 | TENAX THERAPEUTICS, INC.Common Stock | MCGAULEY THOMAS | Purchase |
| Nov 17, 2025 | TENAX THERAPEUTICS, INC.Common Stock | MCGAULEY THOMAS | Purchase |
| Nov 17, 2025 | TENAX THERAPEUTICS, INC.Common Stock | MCGAULEY THOMAS | Purchase |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
TENX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Schneeberger Daniel10% owner ADAR1 Capital Management, LLC10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 331,979 | 1.6588 *Value: 550,686.7652Currency not specified | View ↗ |
| Trade: | Schneeberger Daniel10% owner ADAR1 Capital Management, LLC10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 254,342 | 1.5952 *Value: 405,726.3584Currency not specified | View ↗ |
| Trade: | Schneeberger Daniel10% owner ADAR1 Capital Management, LLC10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 336,528 | 1.5066 *Value: 507,013.0848Currency not specified | View ↗ |
| Trade: | Rich StuartChief Medical Officer · Director | PurchaseCommon StockNon-derivative security · Code P | 2,500 | 10.2168 *Value: 25,542Currency not specified | View ↗ |
| Trade: | Rich StuartChief Medical Officer · Director | PurchaseCommon StockNon-derivative security · Code P | 2,500 | 10.1002 *Value: 25,250.5Currency not specified | View ↗ |
| Trade: | Rich StuartChief Medical Officer · Director | PurchaseCommon StockNon-derivative security · Code P | 2,500 | 9.1992Value: 22,998Currency not specified | View ↗ |
| Trade: | Rich StuartChief Medical Officer · Director | PurchaseCommon StockNon-derivative security · Code P | 1,500 | 9.0786 *Value: 13,617.9Currency not specified | View ↗ |
| Trade: | Rich StuartChief Medical Officer · Director | PurchaseCommon StockNon-derivative security · Code P | 1,000 | 9.0059 *Value: 9,005.9Currency not specified | View ↗ |
| Trade: | Giordano Christopher ThomasCEO · Director | PurchaseCommon StockNon-derivative security · Code P | 538 | 7.5887 *Value: 4,082.7206Currency not specified | View ↗ |
| Trade: | Giordano Christopher ThomasCEO · Director | PurchaseCommon StockNon-derivative security · Code P | 455 | 7.5091 *Value: 3,416.6405Currency not specified | View ↗ |
| Trade: | Giordano Christopher ThomasCEO · Director | PurchaseCommon StockNon-derivative security · Code P | 1,612 | 7.7546 *Value: 12,500.4152Currency not specified | View ↗ |
| Trade: | MCGAULEY THOMASInterim CFO | PurchaseCommon StockNon-derivative security · Code P | 5,000 | 7.228 *Value: 36,140Currency not specified | View ↗ |
| Trade: | MCGAULEY THOMASInterim CFO | PurchaseCommon StockNon-derivative security · Code P | 1,000 | 7.35Value: 7,350Currency not specified | View ↗ |
| Trade: | MCGAULEY THOMASInterim CFO | PurchaseCommon StockNon-derivative security · Code P | 2,000 | 7.337 *Value: 14,674Currency not specified | View ↗ |
14 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →